✦ LIBER ✦

Drug Discovery and Target Validation

✍ Scribed by Nuttall, Mark E.

Book ID: 119983877
Publisher: S. Karger AG
Year: 2001
Tongue: English
Weight: 325 KB
Volume: 169
Category: Article
ISSN: 1422-6405
DOI: 10.1159/000047890

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Screening the receptorome: an efficient

Screening the receptorome: an efficient approach for drug discovery and target validation

✍ Ryan T. Strachan; Gina Ferrara; Bryan L. Roth 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 543 KB

Ribozymes in gene identification, target

Ribozymes in gene identification, target validation and drug discovery

✍ Jon E. Chatterton; Xiuyuan Hu; Flossie Wong-Staal 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Recent development of RNAi in drug targe

Recent development of RNAi in drug target discovery and validation

✍ Guohong Liu; Flossie Wong-Staal; Qi-Xiang Li 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 402 KB

Target identification and validation in

Target identification and validation in drug discovery: the role of proteomics

✍ Karla K. Kopec; Donna Bozyczko-Coyne; Michael Williams 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

The discovery and validation of new drug

The discovery and validation of new drug targets in cancer

✍ Sara A Courtneidge; Greg D Plowman 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 672 KB

Advances in our understanding of the signal transduction pathways involved in cellular growth control have provided several new strategies for cancer therapy. Recent advances now make it possible to develop selective inhibitors targeting genomic instability, the growth, survival, and invasion of the

Exposing oncogenic dependencies for canc

Exposing oncogenic dependencies for cancer drug target discovery and validation using RNAi

✍ Quinn L Deveraux; Pedro Aza-Blanc; Klaus W Wagner; Dirk Bauerschlag; Michael P C 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 245 KB